Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers

Real-world experience with the use of diazoxide among people living with congenital hyperinsulinism and their caregivers

IntroductionCongenital hyperinsulinism (HI) is a rare disease that causes severe hypoglycemia. Diazoxide is the first-line treatment; however, many individuals using diazoxide continue to experience hypoglycemia. Diazoxide is associated with side effects that impact life and well-being.MethodsThe st...

Full description

Saved in:
Bibliographic Details
Main Authors: Tai L. S. Pasquini, Kristen E. Rohli, Fiona J. Almeida, Indraneel Banerjee, Antonia Dastamani, Diva D. De Leon, Lauren N. Lopez, Paul S. Thornton, Julie Raskin
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Endocrinology
Subjects:
congenital hyperinsulinism
hypoglycemia
diazoxide
rare diseases
endocrinology
natural history
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1628125/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items